BIG against breast cancer would like to introduce you to the talented scientists doing BIG research all over the world. Please meet Dr Alast…read more
Dr. Olivia Pagani is Clinical Director of the Breast Unit of Southern Switzerland and Responsible for Breast Cancer at the Institute of Onc…read more
BIG has now finalised the full AURORA protocol and is setting up all the logistics related to this challenging programme. The programme’s fi…read more
Breast cancer is the most common female malignancy, with about 15% of patients being diagnosed during their reproductive years. Although sev…read more
BIG would like to introduce you to the talented scientists doing BIG research all over the world. In that spirit, BIG will issue, on a regu…read more
IBIS II (International Breast Cancer Prevention Study II) is an international clinical trial supported by the Breast International Group (BI…read more
During the last San Antonio Breast Cancer Symposium (SABCS) that took place in December 2013, Dr Martine Piccart presented – on behalf of th…read more
Over the past 18 years, a Parisian charity event “Les Sapins de Noël des Créateurs” (The Designers’ Christmas Trees) has called upon renowne…read more
Great progress has been made, but cancer incidence continues to grow. In Western countries, research and screening programs have successfully reduced the mortality rate but the number of patients diagnosed has actually increased over time (+66% since 1975). Today, a woman’s chance of getting breast cancer is 1 in 8.
Chaired by Dr Martine Piccart and Dr Aron Goldhirsch, BIG’s mission is to facilitate breast cancer research internationally. To fulfil its mission, BIG can count on a network of more than 3.000 hospitals and more than 10.000 doctors and researchers!
AURORA, a Metastatic breast cancer GPS
Academic programme “AURORA” (previously called PRISM-BC)
Metastatic cancer represents the leading cause of death among breast cancer patients, and little progress has been made until now. By using the latest technologies to “molecularly screen” patients tumours, the GPS project aims to analyse the mechanisms of resistance to treatment (why some patients’ tumours respond poorly), to understand the sensitivity to treatment (why some patients’ tumours respond well) and to track the natural progression of the disease. This will be the first large-scale international programme of its kind to focus on metastatic breast cancer, in the hope of significantly improving patients’ lives.
Breast cancer poses many challenges. Scientists have discovered that it is not just one disease, but that it has many variations! To understand any one of these variations and to develop effective treatments, it is necessary to study biological samples and data from thousands of patients. Access to so many patients at one time is only possible if researchers from around the globe commit to working together.
BIG brings together the best breast cancer researchers from around the world to collaborate to find a cure. Many people are still affected. The fight is far from over. Therefore, we need greater awareness from around the world to find out more.
Her Majesty The Queen of the Belgians